# Surrogate Endpoints for Clinical Trials in Kidney Transplantation; Notice of Public Workshop; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of Monday, August 3, 2015 (80 FR 45999). The document announced a public workshop entitled “Surrogate Endpoints for Clinical Trials in Kidney Transplantation.” The document was published without the email address and fax number in the *Contact Person* section and without the option for email or phone registration in the *Registration* section. This document corrects those errors.
**FOR FURTHER INFORMATION CONTACT:**
Ramou Pratt, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6193, Silver Spring, MD 20993-0002, 301-796-3928 or 301-796-1600, FAX: 301-595-7993, *[email protected].*
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 2015-18911, appearing on page 45999 in the *Federal Register* of Monday, August 3, 2015, the following corrections are made:
1. On page 45999, in the first column, the *Contact Person* section is corrected to read: “ *Contact Person:* Ramou Pratt, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6193, Silver Spring, MD 20993-0002, 301-796-3928 or 301-796-1600, FAX: 301-595-7993, *[email protected]* .”
2. On page 45999, in the second column, the *Registration* section is corrected to read: “ *Registration:* Email, fax, or phone your registration information (including name, title, firm name, address, telephone and fax numbers) to Ramou Pratt (see *Contact Person* ) by September 25, 2015. Registration is free for the public workshop. Early registration is recommended because seating is limited. Registration on the day of the public workshop will be provided on a space-available basis beginning at 8 a.m.
If you need special accommodations because of a disability, please contact Ramou Pratt (see *Contact Person* ) at least 7 days in advance.”
Dated: August 19, 2015.
Leslie Kux,
Associate Commissioner for Policy.